Introduction: Treatment options for recurrent C3 glomerulopathy (C3G) are not explored in large trials. Only Eculizumab has been successfully used to improve the renal function in patients with recurrent C3G. In the current report. we are sharing our experience with plasma exchange (PLEX) in the management of early recurrent C3G post-renal transplantation. https://www.roneverhart.com/117-Varick-Street-Tribeca-NY-1914/